Mutual of America Capital Management LLC Grows Stake in Humana Inc. (NYSE:HUM)

Mutual of America Capital Management LLC boosted its stake in shares of Humana Inc. (NYSE:HUM) by 1.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 19,322 shares of the insurance provider’s stock after acquiring an additional 290 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Humana were worth $7,220,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. CarsonAllaria Wealth Management Ltd. increased its position in shares of Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares during the last quarter. Hantz Financial Services Inc. purchased a new position in Humana during the second quarter worth $35,000. Family Firm Inc. bought a new position in Humana during the second quarter valued at $37,000. Riverview Trust Co purchased a new stake in shares of Humana in the second quarter valued at $44,000. Finally, Carolinas Wealth Consulting LLC lifted its holdings in shares of Humana by 274.1% in the 4th quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock worth $46,000 after acquiring an additional 74 shares during the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Price Performance

Shares of HUM stock opened at $312.00 on Friday. The company has a market cap of $37.60 billion, a P/E ratio of 19.43, a PEG ratio of 2.56 and a beta of 0.50. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.66 and a quick ratio of 1.66. The stock’s 50-day moving average is $359.14 and its 200 day moving average is $345.90. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm had revenue of $29.54 billion for the quarter, compared to the consensus estimate of $28.52 billion. During the same quarter in the previous year, the firm earned $8.94 EPS. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. Research analysts predict that Humana Inc. will post 16 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be issued a dividend of $0.885 per share. The ex-dividend date is Monday, September 30th. This represents a $3.54 annualized dividend and a dividend yield of 1.13%. Humana’s dividend payout ratio is presently 22.04%.

Wall Street Analyst Weigh In

HUM has been the topic of several analyst reports. Oppenheimer upped their price target on shares of Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a report on Thursday, August 1st. Morgan Stanley assumed coverage on Humana in a report on Monday, June 24th. They issued an “equal weight” rating and a $374.00 price target on the stock. Cantor Fitzgerald restated a “neutral” rating and set a $395.00 price objective on shares of Humana in a report on Tuesday, September 10th. TD Cowen increased their target price on Humana from $396.00 to $407.00 and gave the stock a “buy” rating in a research note on Wednesday, July 24th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on Humana from $341.00 to $349.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Thirteen investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, Humana has an average rating of “Hold” and a consensus price target of $398.70.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.